BDNF and DYRK1A are variable and inversely correlated in lymphoblastoid cell lines from down syndrome patients

Molecular Neurobiology

Volumn 46, Issue 2, 2012, Pages 297-303

  Tlili, Asma ^a   Hoischen, Alexander ^b   Ripoll, Clémentine ^a   Benabou, Eva ^a   Badel, Anne ^c   Ronan, Anne ^d   Touraine, Renaud ^e   Grattau, Yann ^f   Stora, Samantha ^f   Van Bon, Bregje ^b   De Vries, Bert ^b   Menten, Björn ^g   Bockaert, Nele ^g   Gecz, Joseph ^h   Antonarakis, Stylianos E ⁱ   Campion, Dominique ^j   Potier, Marie Claude ^k   Bléhaut, Henri ^l   Delabar, Jean Maurice ^a   Janel, Nathalie ^a  

^a Groupe Hospitalier Pitié Salpêtrière   (France)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d Hunter Health   (Australia)

^e HÔPITAL NORD   (France)

^f Institut Jerome Lejeune   (France)

^g GHENT UNIVERSITY HOSPITAL   (Belgium)

^h UNIVERSITY OF ADELAIDE   (Australia)

ⁱ UNIVERSITY OF GENEVA   (Switzerland)

^j INSERM   (France)

^k PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^l Institut Jerome Lejeune   (France)

more..

Author keywords

BDNF; Down syndrome; DYRK1A; Lymphoblastoid cell lines; mRNA; Protein

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DYRK1A PROTEIN; MESSENGER RNA; PROTEIN; UNCLASSIFIED DRUG;

ALLELE; ANEUPLOIDY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHROMOSOME 21; DOWN SYNDROME; GENE OVEREXPRESSION; GENETIC VARIABILITY; GENOMICS; HUMAN; LYMPHOBLASTOID CELL LINE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; TRANSGENIC MOUSE; TRISOMY 21;

EID: 84868142722     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-012-8284-7     Document Type: Article

References (28)

1. Antonarakis SE, Lyle R, Dermitzakis ET, Reymond A, Deutsch S (2004) Chromosome 21 and down syndrome: from genomics to pathophysiology. Nat Rev Genet 5:725-738 (Pubitemid 39336357)
2. Brugge KL, Nichols SL, Salmon DP, Hill LR, Delis DC, Aaron L et al (1994) Cognitive impairment in adults with Down's syndrome: similarities to early cognitive changes in Alzheimer's disease. Neurology 44:232-238 (Pubitemid 24070957)
3. Lebmann V (1998) Neurotrophin-dependent modulation of glutamatergic synaptic transmission in the mammalian CNS. Gen Pharmacol 31:667-674
4. Pezet S, Malcangio M (2004) Brain-derived neurotrophic factor as a drug target for CNS disorders. Expert Opin Ther Targets 8:391-399 (Pubitemid 39359646)
5. Bimonte-Nelson HA, Hunter CL, Nelson ME, Granholm AC (2003) Frontal cortex BDNF levels correlate with working memory in an animal model of Down syndrome. Behav Brain Res 139:47-57 (Pubitemid 36300789)
6. Fukuda Y, Berry TL, NelsonM, Hunter CL, Fukuhara K, Imai H et al (2010) Stimulated neuronal expression of brain-derived neurotrophic factor by neurotropin. Mol Cell Neurosci 45:226-233
7. Bianchi P, Ciani E, Guidi S, Trazzi S, Felice D, Grossi G et al (2010) Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for Down syndrome. J Neurosci 30:8769-8779
8. Toiber D, Azkona G, Ben-Ari S, Torán N, Soreq H, DierssenM(2010) Engineering DYRK1A overdosage yields Down syndrome-characteristic cortical splicing aberrations. Neurobiol Dis 40:348-359
9. Guedj F, Sébrié C, Rivals I, Ledru A, Paly E, Bizot JC et al (2009) Green tea polyphenols rescue of brain defects induced by overexpression of DYRK1A. PLoS One 4:e4606
10. Dierssen M, de Lagrán MM (2006) DYRK1A (dual-specificity tyrosine-phosphorylated and -regulated kinase 1A:a gene with dosage effect during development and neurogenesis. Sci World J 6:1911-1922
11. Altafaj X, Dierssen M, Baamonde C, Martí E, Visa J, Guimerà J et al (2001) Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome. Hum Mol Genet 10:1915-1923 (Pubitemid 32910536)
12. Terracciano A, Sanna S, Uda M, Deiana B, Usala G, Busonero F et al (2010) Genome-wide association scan for five major dimensions of personality. Mol Psychiatry 15:647-656
13. Aït Yahya-Graison E, Aubert J, Dauphinot L, Rivals I, Prieur M, Golfier G et al (2007) Classification of human chromosome 21 gene-expression variations in Down syndrome: impact on disease phenotypes. Am J Hum Genet 81:475-491 (Pubitemid 47330207)
14. Dogliotti G, Galliera E, Licastro F, Corsi MM (2010) Age-related changes in plasma levels of BDNF in Down syndrome patients. Immun Ageing 25:7-12
15. Fujimura H, Altar CA, Chen R, Nakamura T, Nakahashi T, Kambayashi J et al (2002) Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb Haemost 87:728-734 (Pubitemid 34302963)
16. Donovan MJ, Miranda RC, Kraemer R, McCaffrey TA, Tessarollo L, Mahadeo D et al (1995) Neurotrophin and neurotrophin receptors in vascular smooth muscle cells. Regulation of expression in response to injury. Am J Pathol 147:309-324
17. Nakahashi T, Fujimura H, Altar CA, Li J, Kambayashi J, Tandon NN et al (2000) Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor. FEBS Lett 470:113-117 (Pubitemid 30151080)
18. Kerschensteiner M, Gallmeier E, Behrens L, Leal VV, Misgeld T, Klinkert WE et al (1999) Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med 189:865-870 (Pubitemid 29189691)
19. Kermani P, Hempstead B (2007) Brain-derived neurotrophic factor: a newly described mediator of angiogenesis. Trends Cardiovasc Med 17:140-143 (Pubitemid 46670025)
20. Lommatzsch M, Zingler D, Schuhbaeck K, Schloetcke K, Zingler C, Schuff-Werner P et al (2005) The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging 26:115-123 (Pubitemid 39600596)
21. Pruunsild P, Kazantseva A, Aid T, Palm K, Timmusk T (2007) Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters. Genomics 90:397-406 (Pubitemid 47179877)
22. Yang EJ, Ahn YS, Chung KC (2001) Protein kinase Dyrk1 activates cAMP response element-binding protein during neuronal differentiation in hippocampal progenitor cells. J Biol Chem 276:39819-39824
23. Arron JR, Winslow MM, Polleri A, Chang CP, Wu H, Gao X et al (2006) NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 441:595-600 (Pubitemid 43927286)
24. Tao X, Finkbeiner S, Arnold DB, Shaywitz AJ, Greenberg ME (1998) Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 20:709-726 (Pubitemid 28199050)
25. Groth RD,Mermelstein PG (2003) Brain-derived neurotrophic factor activation of NFAT (nuclear factor of activated T-cells)-dependent transcription: a role for the transcription factor NFATc4 in neurotrophin-mediated gene expression. J Neurosci 23:8125-8134 (Pubitemid 37082466)
26. Ahmed MM, Sturgeon X, Ellison M, Davisson MT, Gardiner KJ (2012) Loss of correlations among proteins in brains of the Ts65Dn mouse model of Down syndrome. J Proteome Res 11:1251-1263
27. Lang UE, Hellweg R, Kalus P, Bajbouj M, Lenzen KP, Sander T et al (2005) Association of a functional BDNF polymorphism and anxiety-related personality traits. Psychopharmacology 180:95-99 (Pubitemid 40897075)
28. Virji-Babul N, Eichmann A, Kisly D, Down J, Haslam RH (2007) Use of health care guidelines in patients with Down syndrome by family physicians across Canada. Paediatr Child Health 12:179-183 (Pubitemid 46716123)